Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Voceryq

Pharmaceutical Executive Daily: FDA Approves Voceryq

Published 2 weeks, 2 days ago
Description
FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of digital clone use cases in pharma, and CytoDyn’s Dr. Jay Lalezari on his path from HIV clinician to CEO.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us